Related Experiment Video

Updated: Oct 17, 2026

Tissue Triage and Freezing for Models of Skeletal Muscle Disease
05:58

Tissue Triage and Freezing for Models of Skeletal Muscle Disease

Published on: July 15, 2014

Role of regulatory proteins (troponin-tropomyosin) in pathologic states

A Malhotra1

  • 1Department of Medicine, Montefiore Medical Center, Bronx, NY 10467.

Molecular and Cellular Biochemistry
|June 15, 1994
PubMed

Insights

The troponin-tropomyosin complex plays a key role in regulating muscle contraction. Alterations in this complex are linked to cardiac dysfunction in various disease models, suggesting it

Area of Science:

  • Muscle Physiology
  • Cardiac Regulation
  • Biochemistry

Background:

  • The troponin-tropomyosin (TnTm) complex regulates calcium-mediated muscle contraction in vertebrate striated muscle.
  • Variations in the Tn complex occur across species, during development, and in disease states.
  • Previous research extensively reviewed the roles of tropomyosin and troponin in muscle contraction regulation.

Purpose of the Study:

  • To investigate the role of the troponin-tropomyosin complex in altered myocardial function in various disease models.
  • To determine if abnormalities in myofibrillar ATPase activity could be corrected by manipulating the TnTm complex.

Main Methods:

  • Cardiac myofibrils were isolated from healthy and diseased animal models (dystrophic hamsters, rats with coronary artery narrowing, hypertrophic guinea pigs, myocardial infarcted rats, diabetic-hypertensive rats).
  • Magnesium-dependent and calcium-dependent ATPase activities were measured.
  • Myofibrillar preparations were recombined with troponin-tropomyosin complexes from normal or diseased hearts to assess functional correction.

Main Results:

  • Increased Mg2+ ATPase activity was observed in cardiac myofibrils from dystrophic hamsters and rats with chronic coronary artery narrowing.
  • Abnormalities in cardiomyopathic hamster myofibrillar ATPase activity were corrected by recombining with normal TnTm.
  • Downregulation of Ca2+ Mg2+ ATPase was noted in hypertrophic guinea pig hearts, myocardial infarcted rats, and diabetic-hypertensive rat hearts.
  • Myosin abnormalities in diabetic rats were corrected by adding control troponin-tropomyosin.
  • Disease models showed decreased pure myosin ATPase activities and shifts in myosin heavy chain composition.

Conclusions:

  • The troponin-tropomyosin complex plays a significant role in altered myocardial function across multiple disease models.
  • Molecular alterations within the TnTm complex are directly linked to physiological and pathological changes in cardiac function.
  • Targeting or understanding the TnTm complex may offer therapeutic insights for cardiac diseases.

More Related Videos

A Time-Efficient Fluorescence Spectroscopy-Based Assay for Evaluating Actin Polymerization Status in Rodent and Human Brain Tissues06:54

A Time-Efficient Fluorescence Spectroscopy-Based Assay for Evaluating Actin Polymerization Status in Rodent and Human Brain Tissues

Published on: June 3, 2021

Optogenetic Inhibition of Rho1-Mediated Actomyosin Contractility Coupled with Measurement of Epithelial Tension in Drosophila Embryos12:35

Optogenetic Inhibition of Rho1-Mediated Actomyosin Contractility Coupled with Measurement of Epithelial Tension in Drosophila Embryos

Published on: April 14, 2023

Related Concept Videos

Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Actin and Myosin in Muscle Contraction01:16

Actin and Myosin in Muscle Contraction

Actin and myosin are contractile proteins that form the sarcomere found in skeletal muscle tissues for regulating muscle contraction. Actin, a globular contractile protein, interacts with myosin for muscle contraction. The skeletal tissue appears striped or striated under a microscope due to the repeated arrangement of contractile proteins actin and myosin along the length of myofibrils. Dark A bands and light I bands repeat along myofibrils, and the alignment of myofibrils in the cell causes...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
The Sarcomere01:08

The Sarcomere

A sarcomere is a microscopic segment repeating in a myofibril. The sarcomere fundamentally consists of two main myofilaments: thick filaments called myosin and thin filaments called actin. These filaments interact by sliding past each other in response to stimulus. In addition to myosin and actin, several other proteins, such as tropomyosin, troponin, titin, nebulin, myomesin, α-actinin, and dystrophin, play crucial roles in regulating, structuring, and functioning of the sarcomere.
Each myosin...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...